How did ICUI's recent EPS compare to expectations?
The most recent EPS for ICU Medical Inc is $1.97, beating expectations of $1.78.
How did ICU Medical Inc ICUI's revenue perform in the last quarter?
ICU Medical Inc revenue for the last quarter is $1.97
What is the revenue estimate for ICU Medical Inc?
According to 8 of Wall street analyst, the revenue estimate of ICU Medical Inc range from $564.79M to $515.48M
What's the earning quality score for ICU Medical Inc?
ICU Medical Inc has a earning quality score of B+/51.68051. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does ICU Medical Inc report earnings?
ICU Medical Inc next earnings report is expected in 2026-08-05
What are ICU Medical Inc's expected earnings?
ICU Medical Inc expected earnings is $530.89M, according to wall-street analysts.
Did ICU Medical Inc beat earnings expectations?
ICU Medical Inc recent earnings of $525.77M does not beat expectations.
Key Stats
Prev.Close
$136.14
Open
$136.56
Day's Range
$135.38 - $137.12
52 week range
$107 - $160.29
Volume
204.4K
Avg.Volume
294.2K
Dividend yield
--
EPS (TTM)
1.85
Market Cap
$3.3B
What is ICUI?
ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 15,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.